JSB462
CJSB462A11101
Phase 1 small_molecule active
Quick answer
JSB462 for Metastatic Prostate Cancer (mCRPC) is a Phase 1 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Metastatic Prostate Cancer (mCRPC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active